Day 1: Tuesday, July 16
8 – 8:50 a.m.: Continental Breakfast
Pre-Conference Workshops
Time | Session |
---|---|
9 a.m. – noon | Pre-Conference Workshop: Unlocking the Genetic Code: A Workshop on Cancer Detection |
Pre-Conference Workshop: From Microbes to Medicine: Exploring Bacterial Transformation in Cancer Research | |
12 – 12:30 p.m. | Lunch for workshop participants |
12:30 – 1 p.m.: Conference Registration
Session 1
Time | Session |
---|---|
1 – 1:15 p.m. | Welcome and Introductions |
— | Dietmar W. Siemann, Ph.D. |
1:15 – 2 p.m. | Unleashing the power of mathematics for cancer therapy |
— | Meghan Ferrall-Fairbanks, Ph.D. |
2 – 2:15 p.m. | Exploring vessel plasticity in the tumor microenvironment |
— | Arinola Lampejo |
2:15 – 2:30 p.m. | Break |
Session 2
Time | Session |
---|---|
2:30 – 3:15 p.m. | How man’s best friend helps us understand cancer in humans |
— | Rowan Milner, Ph.D. |
3:15 – 3:30 p.m. | Cancer immunology and immunotherapy |
— | Christiano Marconi |
3:30 – 3:45 p.m. | Break |
Session 3
Time | Session |
---|---|
3:45 – 4:30 p.m. | Lifestyles and cancer |
— | Dietmar W. Siemann, Ph.D. |
4:30 – 5:30 p.m. | CGRC Tour: Interdisciplinary Center for Biotechnology Research (ICBR), Flow Cytometry Core |
5:30 p.m. | Meeting adjourns |
6 – 8 p.m.: Social Mixer at the Hilton University of Florida Conference Center
Day 2: Wednesday, July 17
7:45 a.m. – 8:30 a.m.: Continental Breakfast
Session 4
Time | Session |
---|---|
8:30 – 9:15 a.m. | Non-coding RNAs as predictors of cancer outcomes |
— | Kristianna Fredenburg, M.D., Ph.D. |
9:15 – 10 a.m. | The microbiome and pancreatic cancer |
— | Ryan M. Thomas, M.D. |
10 – 10:30 a.m. | Break |
Session 5
Time | Session |
---|---|
10:30 – 10:45 a.m. | The Team-based Interdisciplinary Cancer Research Training (TICaRT) Program |
— | Dietmar W. Siemann, Ph.D. |
10:45 – 11:15 a.m. | TICaRT Team Presentation: Utilizing chimeras to reverse therapy-induced cachexia |
— | Madison Carelock |
— | Jeremy Ducharme, Ph.D. |
11:15 a.m. – noon | Cancer genetics using lung cancer as a model |
— | Frederic Kaye, M.D. |